Compared to Estimates, Houlihan Lokey (HLI) Q4 Earnings: A Look at Key Metrics

Zacks Zacks Zacksで開く
Compared to Estimates, Houlihan Lokey (HLI) Q4 Earnings: A Look at Key Metrics

For the quarter ended March 2026, Houlihan Lokey (HLI) reported revenue of $635.64 million, down 4.6% over the same period last year. EPS came in at $1.63, compared to $1.96 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $687.1 million, representing a surprise of -7.49%. The company delivered an EPS surprise of -11.53%, with the consensus EPS estimate being $1.84.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Houlihan Lokey performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Number of Managing Directors - Corporate Finance: 251 versus 246 estimated by two analysts on average. Number of Managing Directors - Financial and Valuation Advisory: 44 versus the two-analyst average estimate of 45. Number of Managing Directors - Financial Restructuring: 59 compared to the 60 average estimate based on two analysts. Revenues- Corporate Finance: $433.77 million versus the three-analyst average estimate of $448.84 million. Revenues- Financial and Valuation Advisory: $91.49 million compared to the $95.51 million average estimate based on three analysts. Revenues- Financial Restructuring: $110.38 million versus the three-analyst average estimate of $137.21 million.

View all Key Company Metrics for Houlihan Lokey here>>>

Shares of Houlihan Lokey have returned +5.1% over the past month versus the Zacks S&P 500 composite's +10.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Houlihan Lokey, Inc. (HLI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research